Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO0730699 + Metformin in T2DM
NCT00111631Phase 2Completed
- Sponsor
- Roche
- Start
- May 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of divarasib in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Roche. Primary endpoint: Absolute change from baseline in HbA1c at 16 weeks. Started May 2005; status: completed.
02
Drugs
divarasib
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00111631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111631.